Replies to post #12904 on Sorrento Therapeutics Inc (SRNE)

[1776club]

AGREEDED and here is something to watch and see how it goes. LILLY just received a EUA for bebtelovimab (IV) NCT04634409 completed P2 in 10-2021.

SORRENTO has completed COVI-DROPS Phase 2 NCT04906694 on January 13, 2022, in the USA so, no laughing here, we should get a EUA in May 2022.

Sure thing...no doubt. ;>(

Worried about #2 with Chinese study as it is in the crosshairs of the FDA but as someone said, China alone is a big market. I'd drop that to #4.

I am pulling for your list.

[Brandywhitneylady]

As the stock struggles to stay above $3....

[1776club]

Doesn't look good for #2. You would think this is a major event that the company should notify the stockholders about. Maybe I have missed something but...